National Reference Laboratory (NRL) participated in the Dubai International Neurology Congress 2026, highlighting its advanced neurodiagnostic and biomarker testing capabilities.
Leading neuroglogists, researchers and healthcare professional gathered to explore innovations in neurological diagnosis and treatment and management of various neurological disorders.
In support of early detection, precision medicine and better patient outcomes, NRL showcased its specialized testing portfolio, demonstrating commitment to early detection and precision medicine.